PVI
APYX icon

Pura Vida Investments’s Apyx Medical APYX Stock Holding History

Pura Vida Investments’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80,000
Closed -$210K – 53
2023
Q4 		$210K Sell
80,000
-756,990
-90% -$1.83M 0.03% 50
2023
Q3 		$2.68M Sell
836,990
-151,604
-15% -$706K 0.51% 52
2023
Q2 		$4.97M Sell
988,594
-482,664
-33% -$2.45M 0.66% 42
2023
Q1 		$4.24M Buy
1,471,258
+863,698
+142% +$2.52M 0.43% 51
2022
Q4 		$1.42M Sell
607,560
-900,502
-60% -$2.75M 0.07% 137
2022
Q3 		$6.77M Buy
1,508,062
+184,759
+14% +$1.32M 0.39% 68
2022
Q2 		$7.75M Buy
1,323,303
+340,620
+35% +$1.75M 0.45% 60
2022
Q1 		$6.42M Buy
982,683
+140,100
+17% +$1.38M 0.21% 107
2021
Q4 		$10.8M Sell
842,583
-14,435
-2% -$202K 0.39% 68
2021
Q3 		$11.9M Sell
857,018
-95,027
-10% -$1,000K 0.36% 72
2021
Q2 		$9.82M Sell
952,045
-6,443
-0.7% -$63.8K 0.31% 75
2021
Q1 		$9.26M Buy
958,488
+55,641
+6% +$557K 0.26% 75
2020
Q4 		$6.5M Hold
902,847
– – 0.24% 88
2020
Q3 		$4.25M Buy
902,847
+77,730
+9% +$385K 0.22% 90
2020
Q2 		$4.58M Buy
825,117
+122,668
+17% +$510K 0.44% 59
2020
Q1 		$2.52M Buy
702,449
+128,667
+22% +$864K 0.3% 61
2019
Q4 		$4.85M Buy
573,782
+147,910
+35% +$1.07M 0.43% 56
2019
Q3 		$2.88M Buy
425,872
+28,600
+7% +$203K 0.49% 56
2019
Q2 		$2.67M Buy
+397,272
New +$2.16M 0.41% 73
2017
Q1 		– Sell
-123,000
Closed -$442K – 81
2016
Q4 		$442K Buy
+123,000
New +$548K 0.16% 61

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCA
Greenwood Capital Associates Greenwood, South Carolina $908M AUM 24.22% 1-Year Est. Return

Pura Vida Investments's APYX Position: Q1 2024 in Review

Pura Vida Investments sold out of Apyx Medical (APYX) in Q1 2024, closing a stake of 80,000 shares — an estimated $210K sold.

Pura Vida Investments first reported a position in APYX in Q4 2016 and held it in 20 quarters. The position peaked at $11.9M in Q3 2021. 51 funds tracked by Wall St. Rank hold APYX as of Q1 2024.

  • Pura Vida Investments reported no remaining Apyx Medical position as of Q1 2024 after selling out during the quarter.
  • Pura Vida Investments sold 80,000 Apyx Medical shares in Q1 2024, an estimated $210K.
  • Pura Vida Investments first reported a position in Apyx Medical in Q4 2016 and held it in 20 quarters.
  • Pura Vida Investments's Apyx Medical position peaked at $11.9M in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2024.

Based on Pura Vida Investments's 13F filing for Q1 2024, filed 15 May 2024.